| Financial Year |
March 31 2023 |
| Monetary Funds |
2,539,833,679.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,123,153,472.70 |
| Advances to Suppliers |
40,005,851.80 |
| Other Receivables |
5,760,555.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
28,028,866.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,712,949.45 |
| Total Current Assets |
4,453,208,106.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,841,669,434.75 |
| Under-construction Projects |
2,914,973,226.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,234,422.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
41,772,414.95 |
| Deferred Income Tax Assets |
49,504,851.67 |
| Other Non-Current Assets |
30,090,331.99 |
| Sub-Total of Non-Current Assets |
7,960,705,590.94 |
| Total Assets |
12,413,913,697.93 |
| Short-Term Loans |
1,079,224,861.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
599,000,000.00 |
| Accounts Payable |
1,676,120,444.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,640,248.07 |
| Taxes Payable |
78,120,192.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,129,603.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
360,980,827.23 |
| Other Current Liabilities |
15,901,565.65 |
| Sub-Total of Current Liabilities |
3,967,806,792.46 |
| Long-term Loans |
1,917,100,000.00 |
| Bonds Payable |
998,713,322.76 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
24,670,890.66 |
| Deferred Income Tax Liabilities |
6,612,001.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,001,314,873.87 |
| Total Liabilities |
6,969,121,666.33 |
| Paid-In Capital(Or Share Stock) |
967,502,660.00 |
| Capital Surplus |
975,573,663.77 |
| Surplus Reserve |
549,083,555.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,915,342,666.96 |
| Minority Stockholder's Interest |
22,354,353.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,422,437,678.58 |
| Owner's Equity（Stockholder's Equity） |
5,444,792,031.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,413,913,697.93 |
